» Articles » PMID: 36295098

Oxidative Stress Management in Cardiorenal Diseases: Focus on Novel Antidiabetic Agents, Finerenone, and Melatonin

Overview
Journal Life (Basel)
Specialty Biology
Date 2022 Oct 27
PMID 36295098
Authors
Affiliations
Soon will be listed here.
Abstract

Oxidative stress is characterized by excessive production of reactive oxygen species together with exhausted antioxidant defenses. This constitutes a main pathophysiologic process that is implicated in cardiovascular and renal diseases. In particular, enhanced oxidative stress may lead to low-density lipoprotein accumulation and oxidation, endothelial cell activation, adhesion molecule overexpression, macrophage activation, and foam cell formation, promoting the development and progression of atherosclerosis. The deleterious kidney effects of oxidative stress are numerous, including podocytopathy, mesangial enlargement, renal hypertrophy, tubulointerstitial fibrosis, and glomerulosclerosis. The prominent role of oxidative mechanisms in cardiorenal diseases may be counteracted by recently developed pharmacotherapies such as novel antidiabetic agents and finerenone. These agents have demonstrated significant antioxidant activity in preclinical and clinical studies. Moreover, the use of melatonin as a treatment in this field has been experimentally investigated, with large-scale clinical studies being awaited. Finally, clinical implications and future directions in this field are presented.

Citing Articles

Therapeutic potential of finerenone for diabetic cardiomyopathy: focus on the mechanisms.

Wang J, Xue H, He J, Deng L, Tian J, Jiang Y Diabetol Metab Syndr. 2024; 16(1):232.

PMID: 39289758 PMC: 11409712. DOI: 10.1186/s13098-024-01466-x.


Mitochondrial Melatonin: Beneficial Effects in Protecting against Heart Failure.

Reiter R, Sharma R, de Almeida Chuffa L, Simko F, Dominguez-Rodriguez A Life (Basel). 2024; 14(1).

PMID: 38255703 PMC: 10820220. DOI: 10.3390/life14010088.


XBP1 Modulates the Aging Cardiorenal System by Regulating Oxidative Stress.

Zhang J, Zhao Y, Gong N Antioxidants (Basel). 2023; 12(11).

PMID: 38001786 PMC: 10669121. DOI: 10.3390/antiox12111933.


The role of a novel mineralocorticoid receptor antagonist, finerenone, in chronic kidney disease: mechanisms and clinical advances.

Chen X, Li X, Zhang K, Lian K, Zhang W, Song Y Clin Exp Nephrol. 2023; 28(2):125-135.

PMID: 37847437 DOI: 10.1007/s10157-023-02413-2.


Exogenous melatonin ameliorates steroid-induced osteonecrosis of the femoral head by modulating ferroptosis through GDF15-mediated signaling.

Li W, Li W, Zhang W, Wang H, Yu L, Yang P Stem Cell Res Ther. 2023; 14(1):171.

PMID: 37400902 PMC: 10318673. DOI: 10.1186/s13287-023-03371-y.


References
1.
Xing Y, Liu B, Wan S, Cheng Y, Zhou S, Sun Y . A SGLT2 Inhibitor Dapagliflozin Alleviates Diabetic Cardiomyopathy by Suppressing High Glucose-Induced Oxidative Stress and . Front Pharmacol. 2021; 12:708177. PMC: 8311522. DOI: 10.3389/fphar.2021.708177. View

2.
Zaibi N, Li P, Xu S . Protective effects of dapagliflozin against oxidative stress-induced cell injury in human proximal tubular cells. PLoS One. 2021; 16(2):e0247234. PMC: 7894948. DOI: 10.1371/journal.pone.0247234. View

3.
Takasu C, Vaziri N, Li S, Robles L, Vo K, Takasu M . Treatment With Dimethyl Fumarate Attenuates Calcineurin Inhibitor-induced Nephrotoxicity. Transplantation. 2015; 99(6):1144-50. PMC: 4452388. DOI: 10.1097/TP.0000000000000647. View

4.
Shin H, Jeong S, Lee Y, Jeon C, Kwon G, Kim S . HO-Activatable Antioxidant Polymeric Prodrug Nanoparticles for the Prevention of Renal Ischemia/Reperfusion Injury. Biomacromolecules. 2022; 23(9):3810-3821. DOI: 10.1021/acs.biomac.2c00669. View

5.
Norris K, Olabisi O, Barnett M, Meng Y, Martins D, Obialo C . The Role of Vitamin D and Oxidative Stress in Chronic Kidney Disease. Int J Environ Res Public Health. 2018; 15(12). PMC: 6313656. DOI: 10.3390/ijerph15122701. View